Fig. 1From: Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studiesStudy flowchart of furmonertinib. CNS, central nervous system. cFAS, CNS full analysis set. cEFR, CNS evaluable-for-response setBack to article page